A Phase 1B Study of AZD9291 in Combination with Navitoclax in EGFR-Mutant Non-Small Cell Lung Cancer Following Resistance to Initial EGFR Kinase Inhibitor

IRB/UVA Tracking #
19574
Contact First Name

Gracie Tubbs Hockenberry

Contact Email
Contact Phone
Phase
I
Primary purpose
Treatment
Cancer PI
Ryan Gentzler
Status
OPEN TO ACCRUAL